First, complementary gain-of-function studies using ASNS overexpression in SCLC models will be important to determine whether enforced ASNS expression is sufficient to enhance cell proliferation, migration, and in vivo tumor growth, thereby functionally mirroring the loss-of-function phenotypes described here. This evidence concerns the gene ASNS and neoplasm.